Enrolling Women into HIV Preventive Vaccine Trials: An Ethical Imperative but a Logistical Challenge
Open Access
- 21 February 2006
- journal article
- Published by Public Library of Science (PLoS) in PLoS Medicine
- Vol. 3 (3) , e94
- https://doi.org/10.1371/journal.pmed.0030094
Abstract
Mills and colleagues argue that the challenge of enrolling women into HIV vaccine trials must be overcome in order for trials to be considered ethical, valid, and generalizable.Keywords
This publication has 21 references indexed in Scilit:
- Designing research in vulnerable populations: lessons from HIV prevention trials that stopped earlyBMJ, 2005
- HIV vaccine acceptability among communities at risk: The impact of vaccine characteristicsVaccine, 2005
- Promote HIV Chemoprophylaxis Research, Don't Prevent ItScience, 2005
- The Abandoned Trials of Pre-Exposure Prophylaxis for HIV: What Went Wrong?PLoS Medicine, 2005
- HIV Vaccine Acceptability among Women at Risk: Perceived Barriers and Facilitators to Future HIV Vaccine UptakeAIDS Education and Prevention, 2005
- Challenges for HIV Vaccine Dissemination and Clinical Trial Recruitment: If We Build It, Will They Come?AIDS Patient Care and STDs, 2004
- Barriers to participating in an HIV vaccine trialAIDS, 2004
- Reasons For Not Using Condoms Among Female Sex Workers in IndonesiaAIDS Education and Prevention, 2002
- The 18 UNAIDS Guidance PointsDeveloping World Bioethics, 2001
- Some statistical issues in the design of HIV-1 vaccine and treatment trialsStatistical Methods in Medical Research, 2000